123 related articles for article (PubMed ID: 1380905)
1. Diffusion of tosufloxacin into prostatic tissue.
Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
[TBL] [Abstract][Full Text] [Related]
2. [Concentrations of new quinolone agents in serum and prostate tissue].
Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
[TBL] [Abstract][Full Text] [Related]
3. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
Yamashiro Y; Nunome M; Takahata M; Yasuda T
Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277
[TBL] [Abstract][Full Text] [Related]
4. [Studies on suppurative lesion and bone distribution of peroral antimicrobial agents (LAPC and TFLX) to experimental infected rabbits].
Tanaka M; Satoh T
Shigaku; 1990 Oct; 78(3):527-52. PubMed ID: 2134803
[TBL] [Abstract][Full Text] [Related]
5. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
[TBL] [Abstract][Full Text] [Related]
6. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
[TBL] [Abstract][Full Text] [Related]
7. Penetration of lomefloxacin into human prostatic tissue.
Leroy A; Humbert G; Fillastre JP; Grise P
Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
[TBL] [Abstract][Full Text] [Related]
8. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
Morita M; Hatakeyama T; Suzuki K
Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y
Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
[TBL] [Abstract][Full Text] [Related]
10. [Enoxacin concentration in human prostatic tissue].
Yasumoto R; Kobayakawa H; Asakawa M
Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective analysis of the disposition of tosufloxacin enantiomers in man.
Minami R; Inotsume N; Nakamura C; Nakano M
Eur J Clin Pharmacol; 1993; 45(5):489-91. PubMed ID: 8112381
[TBL] [Abstract][Full Text] [Related]
12. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection].
Sasaki J; Kaneko A; Karakida K; Shiiki K; Sakamoto H; Naitoh H; Yamane N; Tomita F; Katoh H; Yoshida H
Jpn J Antibiot; 1995 Sep; 48(9):1093-118. PubMed ID: 7474331
[TBL] [Abstract][Full Text] [Related]
13. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A
Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752
[TBL] [Abstract][Full Text] [Related]
14. [Single-dose treatment of tosufloxacin (TFLX) for acute uncomplicated cystitis].
Kiyota H; Machida T; Masuda F; Ohishi Y; Onodera S; Suzuki H; Goto H; Kawahara M; Igarashi H; Endou K
Kansenshogaku Zasshi; 1992 Apr; 66(4):529-35. PubMed ID: 1624848
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on tosufloxacin (TFLX) in urology].
Fukushima S; Moriyama M; Miyamoto H; Hosaka M; Kubota Y; Kinoshita Y; Noguchi K; Shuin T; Noguchi S; Yoshimura S
Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K
Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
Yamashiro Y; Shimakura M; Minami S; Fukuoka Y; Yasuda T; Watanabe Y; Narita H; Akama M
Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
[TBL] [Abstract][Full Text] [Related]
18. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
Dorfman M; Barsanti J; Budsberg SC
Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial activities of tosufloxacin against recently obtained clinical isolates].
Ishihara R; Suzuki Y; Tanaka S; Fukayama S; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Jul; 49(7):715-42. PubMed ID: 8828073
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of efficacy of oral quinolone against Streptococcus pneumoniae AND Haemophilus influenzae with the use of Monte Carlo simulation].
Mikamo H; Tanaka K; Watanabe K
Jpn J Antibiot; 2006 Dec; 59(6):468-73. PubMed ID: 17334064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
